Telomerase repeat amplification protocol (TRAP) activity upon recombinant expression and purification of human telomerase in a bacterial system

Debra Hansen, Thirumagal Thiyagarajan, Amy C. Larson, Jeffrey L. Hansen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Telomerase biogenesis is a highly regulated process that solves the DNA end-replication problem. Recombinant expression has so far been accomplished only within a eukaryotic background. Towards structural and functional analyses, we developed bacterial expression of human telomerase. Positive activity by the telomerase repeat amplification protocol (TRAP) was identified in cell extracts of Escherichia coli expressing a sequence-optimized hTERT gene, the full-length hTR RNA with a self-splicing hepatitis delta virus ribozyme, and the human heat shock complex of Hsp90, Hsp70, p60/Hop, Hsp40, and p23. The Hsp90 inhibitor geldanamycin did not affect post-assembly TRAP activity. By various purification methods, TRAP activity was also obtained upon expression of only hTERT and hTR. hTERT was confirmed by tandem mass spectrometry in a ∼120 kDa SDS-PAGE fragment from a TRAP-positive purification fraction. TRAP activity was also supported by hTR constructs lacking the box H/ACA small nucleolar RNA domain. End-point TRAP indicated expression levels within 3-fold of that from HeLa carcinoma cells, which is several orders of magnitude below detection by the direct assay. These results represent the first report of TRAP activity from a bacterium and provide a facile system for the investigation of assembly factors and anti-cancer therapeutics independently of a eukaryotic setting.

Original languageEnglish (US)
Pages (from-to)6-13
Number of pages8
JournalProtein Expression and Purification
Volume123
DOIs
StatePublished - Jul 1 2016
Externally publishedYes

Fingerprint

Telomerase
Small Nucleolar RNA
Hepatitis Delta Virus
Humulus
Catalytic RNA
Tandem Mass Spectrometry
Cell Extracts
DNA Replication
HeLa Cells
Polyacrylamide Gel Electrophoresis
Shock
Hot Temperature
Escherichia coli
Bacteria
Carcinoma

Keywords

  • Escherichia coli
  • hTERT
  • hTR
  • Telomerase
  • TRAP assay

ASJC Scopus subject areas

  • Biotechnology

Cite this

Telomerase repeat amplification protocol (TRAP) activity upon recombinant expression and purification of human telomerase in a bacterial system. / Hansen, Debra; Thiyagarajan, Thirumagal; Larson, Amy C.; Hansen, Jeffrey L.

In: Protein Expression and Purification, Vol. 123, 01.07.2016, p. 6-13.

Research output: Contribution to journalArticle

@article{1b42c15fb08b4f549471d30f46c89db6,
title = "Telomerase repeat amplification protocol (TRAP) activity upon recombinant expression and purification of human telomerase in a bacterial system",
abstract = "Telomerase biogenesis is a highly regulated process that solves the DNA end-replication problem. Recombinant expression has so far been accomplished only within a eukaryotic background. Towards structural and functional analyses, we developed bacterial expression of human telomerase. Positive activity by the telomerase repeat amplification protocol (TRAP) was identified in cell extracts of Escherichia coli expressing a sequence-optimized hTERT gene, the full-length hTR RNA with a self-splicing hepatitis delta virus ribozyme, and the human heat shock complex of Hsp90, Hsp70, p60/Hop, Hsp40, and p23. The Hsp90 inhibitor geldanamycin did not affect post-assembly TRAP activity. By various purification methods, TRAP activity was also obtained upon expression of only hTERT and hTR. hTERT was confirmed by tandem mass spectrometry in a ∼120 kDa SDS-PAGE fragment from a TRAP-positive purification fraction. TRAP activity was also supported by hTR constructs lacking the box H/ACA small nucleolar RNA domain. End-point TRAP indicated expression levels within 3-fold of that from HeLa carcinoma cells, which is several orders of magnitude below detection by the direct assay. These results represent the first report of TRAP activity from a bacterium and provide a facile system for the investigation of assembly factors and anti-cancer therapeutics independently of a eukaryotic setting.",
keywords = "Escherichia coli, hTERT, hTR, Telomerase, TRAP assay",
author = "Debra Hansen and Thirumagal Thiyagarajan and Larson, {Amy C.} and Hansen, {Jeffrey L.}",
year = "2016",
month = "7",
day = "1",
doi = "10.1016/j.pep.2016.03.001",
language = "English (US)",
volume = "123",
pages = "6--13",
journal = "Protein Expression and Purification",
issn = "1046-5928",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Telomerase repeat amplification protocol (TRAP) activity upon recombinant expression and purification of human telomerase in a bacterial system

AU - Hansen, Debra

AU - Thiyagarajan, Thirumagal

AU - Larson, Amy C.

AU - Hansen, Jeffrey L.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Telomerase biogenesis is a highly regulated process that solves the DNA end-replication problem. Recombinant expression has so far been accomplished only within a eukaryotic background. Towards structural and functional analyses, we developed bacterial expression of human telomerase. Positive activity by the telomerase repeat amplification protocol (TRAP) was identified in cell extracts of Escherichia coli expressing a sequence-optimized hTERT gene, the full-length hTR RNA with a self-splicing hepatitis delta virus ribozyme, and the human heat shock complex of Hsp90, Hsp70, p60/Hop, Hsp40, and p23. The Hsp90 inhibitor geldanamycin did not affect post-assembly TRAP activity. By various purification methods, TRAP activity was also obtained upon expression of only hTERT and hTR. hTERT was confirmed by tandem mass spectrometry in a ∼120 kDa SDS-PAGE fragment from a TRAP-positive purification fraction. TRAP activity was also supported by hTR constructs lacking the box H/ACA small nucleolar RNA domain. End-point TRAP indicated expression levels within 3-fold of that from HeLa carcinoma cells, which is several orders of magnitude below detection by the direct assay. These results represent the first report of TRAP activity from a bacterium and provide a facile system for the investigation of assembly factors and anti-cancer therapeutics independently of a eukaryotic setting.

AB - Telomerase biogenesis is a highly regulated process that solves the DNA end-replication problem. Recombinant expression has so far been accomplished only within a eukaryotic background. Towards structural and functional analyses, we developed bacterial expression of human telomerase. Positive activity by the telomerase repeat amplification protocol (TRAP) was identified in cell extracts of Escherichia coli expressing a sequence-optimized hTERT gene, the full-length hTR RNA with a self-splicing hepatitis delta virus ribozyme, and the human heat shock complex of Hsp90, Hsp70, p60/Hop, Hsp40, and p23. The Hsp90 inhibitor geldanamycin did not affect post-assembly TRAP activity. By various purification methods, TRAP activity was also obtained upon expression of only hTERT and hTR. hTERT was confirmed by tandem mass spectrometry in a ∼120 kDa SDS-PAGE fragment from a TRAP-positive purification fraction. TRAP activity was also supported by hTR constructs lacking the box H/ACA small nucleolar RNA domain. End-point TRAP indicated expression levels within 3-fold of that from HeLa carcinoma cells, which is several orders of magnitude below detection by the direct assay. These results represent the first report of TRAP activity from a bacterium and provide a facile system for the investigation of assembly factors and anti-cancer therapeutics independently of a eukaryotic setting.

KW - Escherichia coli

KW - hTERT

KW - hTR

KW - Telomerase

KW - TRAP assay

UR - http://www.scopus.com/inward/record.url?scp=84962596439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962596439&partnerID=8YFLogxK

U2 - 10.1016/j.pep.2016.03.001

DO - 10.1016/j.pep.2016.03.001

M3 - Article

C2 - 26965413

AN - SCOPUS:84962596439

VL - 123

SP - 6

EP - 13

JO - Protein Expression and Purification

JF - Protein Expression and Purification

SN - 1046-5928

ER -